In a lymphoma mouse model, a TLR9 agonist (intratumoral CpG) in combination with anti-OX40 and anti-CTLA-4 cured large and systemic lymphoma tumors without the need for chemotherapy [112]. Here, TLR9 is linked to lymphoma.